Stallion India Reaffirms FY26 Revenue Growth Guidance of 30-35%
Stallion India Fluorochemicals reaffirms FY26 revenue growth guidance of 30-35%. The R-32 project is on schedule for commercial commencement by July 2026 and is expected to generate around ₹500 crore in annual revenue.
Reaffirmation of revenue growth guidance and progress on the R-32 project are positive indicators. The project is expected to generate ₹500 crore in annual revenue.
The company reaffirmed its FY26 revenue growth guidance and the R-32 project is progressing well and is on schedule for commercial commencement by July 2026. Also, the company has received customer calls for advance order bookings and contracts.
* Stallion India Fluorochemicals Limited (SIFL) reaffirmed its FY26 revenue growth guidance of 30–35%. * Funds from a small promoter stake sale were introduced interest-free into the company. * Funds are being used for: * Purchase of additional land for expansions. * Appointment of EPC contractors for the R-32 project in Bhilwara. * Agreement and payment to the Process Technology Company for technology transfer. * Pre-construction work commencement. * Plant and Machinery orders with advances. * The R-32 project is on schedule for commercial commencement by July 2026 and is expected to generate around ₹500 crore in annual revenue with PAT margins around 22%. * Environmental and regulatory clearances are expected shortly. * The company has received customer calls for advance order bookings and contracts.
What to do with a filing like this
Stallion India Fluorochemicals Limited filed this with the NSE as a statutory disclosure, categorised under press release. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Stallion India Fluorochemicals Limited. Read the original for the full detail.